CD4 and colorectal carcinoma: Among lymphocytes, CD4+ T cells are well-known for their role in anti-tumor responses either through direct action and/or by recruitment of other immune cells.7 These cells are strong candidates for contributing to the protective effect of lymphocyte count against CRC risk.